Journal articles on the topic 'Strophanthinum'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 45 journal articles for your research on the topic 'Strophanthinum.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Shah, Yatin. "Strophanthin – ein besonderes Herzglykosid." Zeitschrift für Komplementärmedizin 3, no. 02 (April 2011): 48–51. http://dx.doi.org/10.1055/s-0030-1270928.
Full textSchmidramsi, H., B. Ostermayr, and J. v. Arnim. "Proving of g-strophanthin." British Homoeopathic journal 82, no. 4 (October 1993): 269. http://dx.doi.org/10.1016/s0007-0785(05)80679-9.
Full textTsyvunin, V. V., S. Yu Shtrygol, D. V. Shtrygol, and D. P. Kavraiskyi. "Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study." Acta Medica Leopoliensia 27, no. 1-2 (June 2021): 63–69. http://dx.doi.org/10.25040/aml2021.01-02.063.
Full textVilensky, L. "Strofantin and novazurol for heart disease." Kazan medical journal 20, no. 9 (August 11, 2021): 990–91. http://dx.doi.org/10.17816/kazmj77072.
Full textMcKenzie, A. G. "The rise and fall of strophanthin." International Congress Series 1242 (December 2002): 95–100. http://dx.doi.org/10.1016/s0531-5131(02)00729-x.
Full textDadashyan, A. M. "Experience in the use of convallotoxin in circulatory failure." Kazan medical journal 43, no. 5 (November 16, 2021): 52–53. http://dx.doi.org/10.17816/kazmj87787.
Full textFrost, Jørgen, and Erik Warburg. "Clinical experiences concerning the effect of strophanthin." Acta Medica Scandinavica 130, S206 (April 24, 2009): 132–44. http://dx.doi.org/10.1111/j.0954-6820.1948.tb12030.x.
Full textIonova, E. O., I. A. Miroshkina, A. V. Sorokina, and S. A. Kryzhanovskii. "Comparative evaluation of echocardiographic and morphometric characteristics of the rat heart left ventricle." Pharmacokinetics and Pharmacodynamics, no. 1 (May 10, 2023): 41–44. http://dx.doi.org/10.37489/2587-7836-2023-1-41-44.
Full textGrosa, Giorgio, Gianna Allegrone, and Erika Del Grosso. "LC–ESI-MS/MS characterization of strophanthin-K." Journal of Pharmaceutical and Biomedical Analysis 38, no. 1 (June 2005): 79–86. http://dx.doi.org/10.1016/j.jpba.2004.12.008.
Full textOlesin, A. I., I. V. Konstantinova, N. N. Tyuteleva, and V. S. Ivanov. "Clinical and prognostic significance of left ventricular dysfunction predictors in patients with ventricular ectopy and without structural heart disease." Fundamental and Clinical Medicine 8, no. 3 (September 29, 2023): 53–67. http://dx.doi.org/10.23946/2500-0764-2023-8-3-53-67.
Full textArnim, H. Schmidramsl; B. Ostermayr; J. v. "g-Strophanthin - Ergebnisse von 2 Arzneimittelprüfungen mit der 4. Dezimalpotenz." Allgemeine Homöopathische Zeitung 238, no. 03 (April 4, 2007): 106–9. http://dx.doi.org/10.1055/s-2006-936451.
Full textChekman, I. S., N. A. Gorchakova, V. V. Bratus', and I. S. Mudraya. "Combined inotropic effect of strophanthin and calcium on heart muscle." Bulletin of Experimental Biology and Medicine 99, no. 3 (March 1985): 317–20. http://dx.doi.org/10.1007/bf00799077.
Full textGalenko-Yaroshevskii, P. A., S. M. Lemkina, and Ya V. Kostin. "Drug correction of impaired strophanthin tolerance during simulated cardiac decompensation." Bulletin of Experimental Biology and Medicine 117, no. 5 (May 1994): 483–86. http://dx.doi.org/10.1007/bf02444295.
Full textBogus, Saida K., Pavel A. Galenko-Yaroshevsky, Konstantin F. Suzdalev, Galina V. Sukoyan, and Valery G. Abushkevich. "2-phenyl-1-(3-pyrrolidin-1-il-propyl)-1 H-indole hydrochloride (SS-68): Antiarrhythmic and cardioprotective activity and its molecular mechanisms of action (Part I)." Research Results in Pharmacology 4, no. 1 (August 31, 2018): 130–55. http://dx.doi.org/10.3897/rrpharmacology.4.28592.
Full textTawfik, Hoda, Alanna A. L. Fox, and Kurt Greeff. "Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides." Biochemical Pharmacology 34, no. 14 (July 1985): 2541–47. http://dx.doi.org/10.1016/0006-2952(85)90540-4.
Full textKarsanov, N. V., G. V. Sukoyan, D. R. Tatulashvili, V. N. Karsanov, and L. D. Mamulashvili. "Difference between mechanisms of action ofβ-acetyldigoxin, strophanthin K, and ouabain." Bulletin of Experimental Biology and Medicine 113, no. 2 (February 1992): 186–89. http://dx.doi.org/10.1007/bf00791495.
Full textKrupin, Theodore, Lisa F. Rosenberg, Arnold L. Sandridge, Charles J. Bock, Adrienne Berman, and Jon M. Ruderman. "Effects of Topical K-Strophanthin on Aqueous Humor and Corneal Dynamics." Journal of Glaucoma 4, no. 5 (October 1995): 327???333. http://dx.doi.org/10.1097/00061198-199510000-00006.
Full textZENG, YONG-CHUN, ZHENG-JUN JIN, and PEI-KUN GU. "Retinal Toxicity in Albino Rabbits Induced by Intravitreal Injection of Strophanthin-K." Journal of Ocular Pharmacology and Therapeutics 6, no. 1 (January 1990): 51–60. http://dx.doi.org/10.1089/jop.1990.6.51.
Full textSobieva, Z. I., M. N. Karpova, and E. G. Kryzhanovskaya. "Effect of lithium compounds on cardiac arrhythmias induced by strophanthin in conscious rats." Bulletin of Experimental Biology and Medicine 99, no. 4 (April 1985): 410–13. http://dx.doi.org/10.1007/bf00842725.
Full textKudryavtseva, N. P., V. I. Kachurets, and S. X. Nasibullina. "The use of strophanthin in the complex treatment of cardiovascular disorders in toxic diphtheria." Kazan medical journal 43, no. 3 (October 29, 2021): 42–43. http://dx.doi.org/10.17816/kazmj83692.
Full textÖSTLING, GUSTAF. "The Significance of the Speed of Injection for the Therapeutic Effect of K-Strophanthin." Acta Medica Scandinavica 129, no. 1 (April 24, 2009): 77–80. http://dx.doi.org/10.1111/j.0954-6820.1947.tb09286.x.
Full textGuang-tian, Yang, and S. Daum. "Wirkung von Strophanthin, Digoxin und Isoproterenol auf die Herzkontraktilität während Hypoxie und hyperkapnischer Azidose." Journal of Tongji Medical University 6, no. 4 (December 1986): 199–205. http://dx.doi.org/10.1007/bf02909745.
Full textSergeev, P. V., P. A. Galenko-Yaroshevskii, S. M. Lemkina, and Ya V. Kostin. "Comparative evaluation of pharmacological effects of combined application of strophanthin with some antiadrenergic agents." Bulletin of Experimental Biology and Medicine 119, no. 5 (May 1995): 484–87. http://dx.doi.org/10.1007/bf02543436.
Full textPogorelova, V. N., A. I. Panait, and A. G. Pogorelov. "Nonspecific effect of Na+/K+-ATPase inhibition with strophanthin or under hypothermia in rat heart." Biophysics 59, no. 5 (September 2014): 768–71. http://dx.doi.org/10.1134/s0006350914050212.
Full textRajabzoda, M. M. "Consequences of road transportation accidents, their standard growth, modern management and tactics of treatment of victims." Health care of Tajikistan, no. 2 (July 21, 2022): 82–87. http://dx.doi.org/10.52888/0514-2515-2022-353-2-83-88.
Full textBauer, N., G. Scheiner-Bobis, and W. Schoner. "„Endogenes Digitalis” – der lange Weg vom herzwirksamen pflanzlichen Toxin zum Hormon der Säuger." Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 34, no. 06 (2006): 389–97. http://dx.doi.org/10.1055/s-0037-1622553.
Full textSørensen, Else Vigholt, and Folmer Nielsen-Kudsk. "Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart." European Journal of Pharmacology 125, no. 3 (June 1986): 363–71. http://dx.doi.org/10.1016/0014-2999(86)90792-2.
Full textMikhailov, I. B. "Effect of strophanthin and digoxin on activity of an experimental epileptogenic focus in the frog hippocampus." Bulletin of Experimental Biology and Medicine 104, no. 5 (November 1987): 1572–74. http://dx.doi.org/10.1007/bf00845084.
Full textFazulzyanov, A. A., V. M. Andreev, and G. N. Fazulzyanova. "Respiratory mechanics, alveolar ventilation, ventilation-perfusion relations in the correction of heart failure with strophanthin and kapoten." Kazan medical journal 76, no. 6 (November 15, 1995): 417–19. http://dx.doi.org/10.17816/kazmj90429.
Full textBonah, Christian. "‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)." History and Technology 29, no. 2 (June 2013): 135–52. http://dx.doi.org/10.1080/07341512.2013.833039.
Full textHassan, A. B., M. Atef, and I. M. Shihata. "Effect of Digoxin and Strophanthin on Renal Blood Flow and Systemic Blood Pressure in Normal and Bled Dogs." Zentralblatt für Veterinärmedizin Reihe A 26, no. 2 (May 13, 2010): 152–58. http://dx.doi.org/10.1111/j.1439-0442.1979.tb00660.x.
Full textGalenko-Yaroshevskii, P. A., S. M. Lemkina, and Ya V. Kostin. "Effects of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacological effects of strophanthinin vivo andin vitro." Bulletin of Experimental Biology and Medicine 117, no. 1 (January 1994): 61–64. http://dx.doi.org/10.1007/bf02444082.
Full textKarsanov, N. V., T. N. Macharashvili, and V. A. Magaldadze. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the contractile protein system of normal cardiomyocytes." Bulletin of Experimental Biology and Medicine 108, no. 6 (December 1989): 1735–38. http://dx.doi.org/10.1007/bf00841047.
Full textGalenko-Yaroshevskii, P. A., S. M. Lernkina, and Ya V. Kostin. "Correction with cordarone of changes in cathepsin D activity induced by modeled circulation insufficiency and toxic action of strophanthin K." Bulletin of Experimental Biology and Medicine 122, no. 4 (October 1996): 1005–7. http://dx.doi.org/10.1007/bf02447021.
Full textGalenko-Yaroshevskii, P. A., S. M. Lemkina, and Ya V. Kostin. "Correction of altered β-glucosidase activity induced by the toxic effect of strophanthin K and modeled cardiac decompensation with cordaron." Bulletin of Experimental Biology and Medicine 121, no. 6 (June 1996): 581–83. http://dx.doi.org/10.1007/bf02447123.
Full textKarsanov, N. V., V. A. Magaldadze, and T. N. Macharashvili. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the myocardial contractile protein system in toxico-allergic cardiomyopathy." Bulletin of Experimental Biology and Medicine 111, no. 5 (May 1991): 698–700. http://dx.doi.org/10.1007/bf00841022.
Full textAgostoni, Pier Giuseppe, Elisabetta Doria, Marco Berti, and Maurizio D. Guazzi. "Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: A double-blind crossover evaluation versus digoxin." Clinical Cardiology 17, no. 10 (October 1994): 536–41. http://dx.doi.org/10.1002/clc.4960171005.
Full textKrvavych, Anna, and Roksolana Konechna. "Optimization of parameters of the extraction process of biologically active substances of grass Adonis vernalis." Technology audit and production reserves 3, no. 3(59) (July 2, 2021): 14–18. http://dx.doi.org/10.15587/2706-5448.2021.235471.
Full textGalust'yan, G. �., and I. B. Mikhailov. "Effect of strophanthin and digoxin on succinate and lactate dehydrogenase and membrane Na+, K+-ATPase activity in the heart of rats with experimental myocarditis." Bulletin of Experimental Biology and Medicine 107, no. 4 (April 1989): 498–500. http://dx.doi.org/10.1007/bf00842388.
Full textDanielopolu, D., Marin Popescu, and Gr Gr Popa. "Action of Drugs on Cholinesterase and on the Adrenolytic Factors. Inactivating Action of Eserine, Strophanthin and Ascorbic Acid on Cholinesterase and on the Adrenolytic Factors." Acta Pharmacologica et Toxicologica 4, no. 3-4 (March 13, 2009): 339–50. http://dx.doi.org/10.1111/j.1600-0773.1948.tb03356.x.
Full textDatté, J. Y., and A. Ziegler. "Pharmacological investigation on nigrescigenin-a cardenolide fromParquetina nigrescens(Afzel.) Bullock: comparative studies on cardiotonic effects ofParquetina nigrescens, g-strophanthin and noradrenaline in guinea-pig isolated atria." Journal of Pharmacy and Pharmacology 53, no. 6 (June 2001): 859–66. http://dx.doi.org/10.1211/0022357011776018.
Full textSugimoto, Jiro, Seiichi Yuasa, and Masayasu Suzuki. "Comparison of Effects of Alprenolol, Carteolol, Indenolol, Pindolol, Practolol, and Propranolol in Relation to their Beta-Blocking, Local Anaesthetic, Membrane Stabilizing, and Strophanthin-G Cardiotoxicity Antagonizing Actions in Guinea-Pig." Journal of Kansai Medical University 39, no. 4 (1987): 418–29. http://dx.doi.org/10.5361/jkmu1956.39.4_418.
Full textDoepp, Manfred. "May Strophanthin be a valuable cardiac drug ?" American Journal of Medical and Clinical Research & Reviews 02, no. 09 (2023). http://dx.doi.org/10.58372/2835-6276.1069.
Full text"Die Lösung des Herzinfarkt-Problems durch g-Strophanthin." Erfahrungsheilkunde 53, no. 02 (February 2004): 65–73. http://dx.doi.org/10.1055/s-2004-819994.
Full textSharma, Ashish Kumar, Shivam Singh, Mehvish Bhat, Kartik Gill, Mohammad Zaid, Sachin Kumar, Anjali Shakya, et al. "New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models." Scientific Reports 13, no. 1 (September 29, 2023). http://dx.doi.org/10.1038/s41598-023-41942-4.
Full text